Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
USD 0.41
(-8.56%)
USD 0.41
(-8.56%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 135.08 Thousand USD | 0.0% |
| 2022 | - USD | -100.0% |
| 2021 | 62.44 Thousand USD | -51.74% |
| 2020 | 129.37 Thousand USD | 0.0% |
| 2018 | - USD | 0.0% |
| 2017 | - USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 267.02 Thousand USD | 0.0% |
| 2024 Q1 | 288.6 Thousand USD | -100.0% |
| 2023 Q1 | 751.69 Thousand USD | 0.0% |
| 2023 Q3 | 442.8 Thousand USD | -2.05% |
| 2023 FY | 135.08 Thousand USD | 0.0% |
| 2023 Q4 | 135.08 Thousand USD | -69.49% |
| 2023 Q2 | 452.08 Thousand USD | -39.86% |
| 2022 Q4 | - USD | -100.0% |
| 2022 FY | - USD | -100.0% |
| 2022 Q2 | 25.6 Thousand USD | -42.14% |
| 2022 Q1 | 44.25 Thousand USD | -29.13% |
| 2022 Q3 | 6671.00 USD | -73.94% |
| 2021 FY | 62.44 Thousand USD | -51.74% |
| 2021 Q4 | 62.44 Thousand USD | 0.0% |
| 2020 FY | 129.37 Thousand USD | 0.0% |
| 2018 FY | - USD | 0.0% |
| 2017 FY | - USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Journey Medical Corporation | 14.62 Million USD | 99.076% |
| ANI Pharmaceuticals, Inc. | 309.66 Million USD | 99.956% |
| Aquestive Therapeutics, Inc. | 91.07 Million USD | 99.852% |
| Pacira BioSciences, Inc. | 513.79 Million USD | 99.974% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | 74.939% |
| Sunshine Biopharma, Inc. | 539.03 Thousand USD | 74.939% |
| SCYNEXIS, Inc. | 12.15 Million USD | 98.889% |
| Safety Shot Inc | 304.9 Thousand USD | 55.695% |
| Alpha Teknova, Inc. | 13.25 Million USD | 98.981% |
| Collegium Pharmaceutical, Inc. | 489.96 Million USD | 99.972% |
| Bright Green Corporation | 201.78 Thousand USD | 33.052% |
| Dynavax Technologies Corporation | 252.41 Million USD | 99.946% |
| Esperion Therapeutics, Inc. | 501.54 Million USD | 99.973% |
| Cosmos Health Inc. | 3.03 Million USD | 95.549% |
| PainReform Ltd. | 30 Thousand USD | -350.297% |
| China SXT Pharmaceuticals, Inc. | 117.12 Thousand USD | -15.334% |
| Embecta Corp. | 1.62 Billion USD | 99.992% |
| Intra-Cellular Therapies, Inc. | 13.32 Million USD | 98.986% |
| Procaps Group, S.A. | 28.41 Million USD | 99.525% |
| Theratechnologies Inc. | 51.26 Million USD | 99.736% |
| Harrow Health, Inc. | 183.17 Million USD | 99.926% |
| Sonoma Pharmaceuticals, Inc. | 87 Thousand USD | -55.275% |
| Biofrontera Inc. | 804 Thousand USD | 83.198% |
| DURECT Corporation | 2.7 Million USD | 95.0% |
| Supernus Pharmaceuticals, Inc. | 33.19 Million USD | 99.593% |
| Cronos Group Inc. | 1.55 Million USD | 91.335% |
| OptiNose, Inc. | 611 Thousand USD | 77.891% |
| Ironwood Pharmaceuticals, Inc. | 498.3 Million USD | 99.973% |
| Kala Pharmaceuticals, Inc. | 34.19 Million USD | 99.605% |
| RedHill Biopharma Ltd. | 455 Thousand USD | 70.31% |
| Organogenesis Holdings Inc. | 60.74 Million USD | 99.778% |
| Guardion Health Sciences, Inc. | - USD | -Infinity% |
| Cumberland Pharmaceuticals Inc. | 12.78 Million USD | 98.943% |
| Radius Health, Inc. | 339.66 Million USD | 99.96% |
| Universe Pharmaceuticals INC | - USD | -Infinity% |
| ProPhase Labs, Inc. | 10.25 Million USD | 98.683% |
| Phibro Animal Health Corporation | 458.28 Million USD | 99.971% |
| Procaps Group S.A. | 28.41 Million USD | 99.525% |
| Alvotech | 1.02 Billion USD | 99.987% |
| TherapeuticsMD, Inc. | 6.53 Million USD | 97.932% |
| Viatris Inc. | 16.18 Billion USD | 99.999% |
| Rockwell Medical, Inc. | 8.29 Million USD | 98.371% |
| Aytu BioPharma, Inc. | 10.87 Million USD | 98.758% |
| SIGA Technologies, Inc. | 335.99 Thousand USD | 59.794% |
| Tilray Brands, Inc. | 287.93 Million USD | 99.953% |
| Lifecore Biomedical, Inc. | 120.51 Million USD | 99.888% |
| Shineco, Inc. | 10.01 Million USD | 98.651% |
| PetIQ, Inc. | 437.82 Million USD | 99.969% |
| Regencell Bioscience Holdings Limited | - USD | -Infinity% |
| Incannex Healthcare Limited | 210 Thousand USD | 35.672% |
| Neurocrine Biosciences, Inc. | 258.3 Million USD | 99.948% |
| Alimera Sciences, Inc. | 64.48 Million USD | 99.791% |
| Silver Spike Investment Corp. | - USD | -Infinity% |
| Assertio Holdings, Inc. | 38.51 Million USD | 99.649% |
| Petros Pharmaceuticals, Inc. | 6.85 Million USD | 98.03% |
| Clever Leaves Holdings Inc. | 720 Thousand USD | 81.238% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -500.823% |
| Avadel Pharmaceuticals plc | 32.75 Million USD | 99.588% |
| Hempacco Co., Inc. | 5.93 Million USD | 97.722% |
| Talphera, Inc. | - USD | -Infinity% |
| Alvotech | 1.02 Billion USD | 99.987% |
| Eagle Pharmaceuticals, Inc. | 56.21 Million USD | 99.76% |
| Lantheus Holdings, Inc. | 616.12 Million USD | 99.978% |
| Currenc Group, Inc. | 2.5 Million USD | 94.611% |
| Kamada Ltd. | 7.43 Million USD | 98.184% |
| Indivior PLC | 235.66 Million USD | 99.943% |
| Evoke Pharma, Inc. | 5 Million USD | 97.298% |
| Flora Growth Corp. | 942 Thousand USD | 85.659% |
| Cyclo Therapeutics, Inc. | 22.48 Thousand USD | -500.823% |
| Evolus, Inc. | 120.35 Million USD | 99.888% |
| HUTCHMED (China) Limited | 48.18 Million USD | 99.72% |
| Amphastar Pharmaceuticals, Inc. | 589.19 Million USD | 99.977% |
| Akanda Corp. | 2.49 Million USD | 94.59% |